Internal Medicine, Hematology & Oncology · Buffalo, NY
NPI
1962577171
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Elm and Carlton St
Buffalo, NY, 14263
Phone (716) 845-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
245 services
Medicare patients, 2024
96
Average age 72
Drug cost, 2024
$6.4M
561 prescriptions
Company payments, 2025
$3,760
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth A Griffiths was code 99214 (office e&m - established), 58 times for 39 patients. In total Elizabeth A Griffiths billed 245 services in 19 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 58 | 39 | $70.57 | $4,093 |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 22 | $59.34 | $3,145 |
| 38222 Other Organ Systems | Facility | 28 | 22 | $56.09 | $1,570 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 11 | $88.79 | $1,598 |
| 99213 Office E&M - Established | Facility | 16 | 15 | $49.66 | $795 |
| 99238 Hospital Discharge Management | Facility | 15 | 15 | $60.98 | $915 |
| 99215 Office E&M - Established | Facility | 12 | 11 | $108.43 | $1,301 |
By year: 2022 $33K for 495 services; 2023 $18K for 290 services; 2024 $16K for 245 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth A Griffiths prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 56 prescriptions and refills. In total Elizabeth A Griffiths wrote 561 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 56 | 56 | Under 11 | $878K |
| Inqovi Decitabine/Cedazuridine | 42 | 42 | 14 | $332K |
| Hydroxyurea Generic | 40 | 64 | 12 | $1,018 |
| Ojjaara Momelotinib Dihydrochloride | 33 | 33 | Under 11 | $866K |
| Ayvakit Avapritinib | 32 | 32 | Under 11 | $1.8M |
| Tibsovo Ivosidenib | 18 | 18 | Under 11 | $571K |
| Venclexta Venetoclax | 16 | 16 | Under 11 | $42K |
| Imatinib Mesylate Generic | 14 | 14 | Under 11 | $41K |
| Valacyclovir Valacyclovir Hcl | 13 | 25 | Under 11 | $308 |
| Scemblix Asciminib Hydrochloride | 13 | 13 | Under 11 | $196K |
| Duloxetine Hcl Generic | 13 | 15 | Under 11 | $125 |
| Inrebic Fedratinib Dihydrochloride | 12 | 12 | Under 11 | $322K |
| Deferasirox Generic | 12 | 13 | Under 11 | $72K |
| Promacta Eltrombopag Olamine | 12 | 17 | Under 11 | $369K |
| Prednisone Generic | 11 | 12 | Under 11 | $59.5 |
Brand drugs: 303 claims; generic drugs: 258 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth A Griffiths $3,760 ($3,760 in general payments such as food, travel and fees) from 6 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $3,120.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.